drugset
drugset / Trial / NCT03722914

A Study on the Efficacy and Safety of Benzonatate Soft Capsules for Improving Adult Cough Symptoms

NCT03722914 ↗

Phase 3 Unknown 220 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is evaluate the efficay and safety of benzonatate soft capsules for improving adult cough symtoms.

Timeline

Start
2018-03-01
Primary completion
2018-12-31
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzonatate Small molecule 200 mg —

Indications

No indication recorded.